DS
Daiichi Sankyo
Resolving
Resolving brand mentions across new media
Daiichi Sankyo
Resolving brand mentions across new media
Daiichi Sankyo
Arcmira media summary
Browse Daiichi Sankyo interviews, podcasts & event videos — 3 indexed from Columbia Business School & Bloomberg Television, updated May 2026.
Japanese pharmaceutical company whose CEO is interviewed about growth and oncology drugs.
Ken Keller's current organization, a global pharmaceutical company.
The company where Ken Keller currently serves as President and CEO.
Arcmira tracks 3 indexed media appearances or mentions for Daiichi Sankyo, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "India Weighs Emergency Steps to Protect Forex Reserves | Insight with Haslinda Amin 05/12/2026" with transcript-derived context and links when available.
Daiichi Sankyo is connected to Xi-Trump Summit, US-Iran Ceasefire, Leadership and Mentorship in Arcmira's media graph.
3
Mentions
2.2K
Views
The trendline is visible, but the dated evidence behind Daiichi Sankyo is in the premium layer.
“Japanese pharmaceutical company whose CEO is interviewed about growth and oncology drugs.”
“Ken Keller's current organization, a global pharmaceutical company.”
“The company where Ken Keller currently serves as President and CEO.”